Beijing’s MoleculeMind Secures Series A Funding to Accelerate AI Protein Design Innovations

MoleculeMind, a Beijing-based AI protein design platform, has reportedly secured a Series A financing round, raising hundreds of millions of renminbi. The funding was co-led by Cherami Investment and Shenzhen Capital Group, with participation from Sense Capital and EBI Investment. The capital raised will be directed towards enhancing the company’s top-tier composite talent team, developing its AI protein basic large model, and advancing its AI protein optimization design platform, MoleculeOS. Additionally, the funds will support the industrial application and commercialization of AI protein technology. – Flcube.com